Timothy L. Lochmann

861 total citations
14 papers, 376 citations indexed

About

Timothy L. Lochmann is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Timothy L. Lochmann has authored 14 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Genetics. Recurrent topics in Timothy L. Lochmann's work include Virus-based gene therapy research (4 papers), RNA Research and Splicing (4 papers) and Neuroblastoma Research and Treatments (3 papers). Timothy L. Lochmann is often cited by papers focused on Virus-based gene therapy research (4 papers), RNA Research and Splicing (4 papers) and Neuroblastoma Research and Treatments (3 papers). Timothy L. Lochmann collaborates with scholars based in United States and Canada. Timothy L. Lochmann's co-authors include Leslie J. Parent, Anthony C. Faber, Cyril H. Benes, Konstantinos V. Floros, Andrew J. Souers, Patricia Greninger, Krista M. Powell, Darrin V. Bann, Shirley M. Taylor and Ravindar R. Thomas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Timothy L. Lochmann

13 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy L. Lochmann United States 11 266 99 56 55 47 14 376
Abdul Rouf Banday United States 10 263 1.0× 84 0.8× 104 1.9× 58 1.1× 48 1.0× 30 530
Richard Kirkman United States 11 221 0.8× 46 0.5× 46 0.8× 45 0.8× 13 0.3× 18 379
Nene N. Kalu United States 9 160 0.6× 198 2.0× 39 0.7× 110 2.0× 16 0.3× 14 312
Laura Tsujikawa United States 13 550 2.1× 69 0.7× 48 0.9× 29 0.5× 9 0.2× 33 700
Florence Le Roy France 15 430 1.6× 125 1.3× 61 1.1× 55 1.0× 9 0.2× 19 630
Stacy Moore United States 8 110 0.4× 203 2.1× 55 1.0× 118 2.1× 20 0.4× 9 369
Chung-Chieh Chiao Taiwan 11 269 1.0× 79 0.8× 90 1.6× 45 0.8× 6 0.1× 13 395
Patrick Gonzalez France 9 257 1.0× 155 1.6× 123 2.2× 184 3.3× 35 0.7× 15 572
Jessica Koach Australia 13 335 1.3× 66 0.7× 70 1.3× 56 1.0× 59 1.3× 19 473
Edurne Gallastegui Spain 11 249 0.9× 123 1.2× 44 0.8× 15 0.3× 7 0.1× 17 359

Countries citing papers authored by Timothy L. Lochmann

Since Specialization
Citations

This map shows the geographic impact of Timothy L. Lochmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy L. Lochmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy L. Lochmann more than expected).

Fields of papers citing papers by Timothy L. Lochmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy L. Lochmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy L. Lochmann. The network helps show where Timothy L. Lochmann may publish in the future.

Co-authorship network of co-authors of Timothy L. Lochmann

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy L. Lochmann. A scholar is included among the top collaborators of Timothy L. Lochmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy L. Lochmann. Timothy L. Lochmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Krytska, Kateryna, Timothy L. Lochmann, Renata Sano, et al.. (2021). Venetoclax-based Rational Combinations are Effective in Models of MYCN -amplified Neuroblastoma. Molecular Cancer Therapeutics. 20(8). 1400–1411. 13 indexed citations
2.
Heisey, Daniel A.R., Sheeba Jacob, Timothy L. Lochmann, et al.. (2021). Pharmaceutical Interference of the EWS-FLI1–driven Transcriptome By Cotargeting H3K27ac and RNA Polymerase Activity in Ewing Sarcoma. Molecular Cancer Therapeutics. 20(10). 1868–1879. 11 indexed citations
3.
Lochmann, Timothy L., Konstantinos V. Floros, Richard Kurupi, et al.. (2021). Catastrophic ATP loss underlies a metabolic combination therapy tailored for MYCN -amplified neuroblastoma. Proceedings of the National Academy of Sciences. 118(13). 18 indexed citations
4.
5.
Heisey, Daniel A.R., Timothy L. Lochmann, Konstantinos V. Floros, et al.. (2018). The Ewing Family of Tumors Relies on BCL-2 and BCL-XL to Escape PARP Inhibitor Toxicity. Clinical Cancer Research. 25(5). 1664–1675. 22 indexed citations
6.
Lochmann, Timothy L., et al.. (2018). BCL-2 inhibition is a promising therapeutic strategy for small cell lung cancer. Oncoscience. 5(7-8). 218–219. 18 indexed citations
7.
Lochmann, Timothy L., Krista M. Powell, Jungoh Ham, et al.. (2018). Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma. Science Translational Medicine. 10(441). 68 indexed citations
8.
Lochmann, Timothy L., Konstantinos V. Floros, Mitra Naseri, et al.. (2017). Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 Expression. Clinical Cancer Research. 24(2). 360–369. 93 indexed citations
9.
Floros, Konstantinos V., Timothy L. Lochmann, Mark T. Hughes, et al.. (2017). Abstract 3082: Deficient NOXA in HER2-amplified breast cancer drives kinase inhibitor resistance. Cancer Research. 77(13_Supplement). 3082–3082. 1 indexed citations
10.
Lochmann, Timothy L., et al.. (2015). Interplay between the alpharetroviral Gag protein and SR proteins SF2 and SC35 in the nucleus. Frontiers in Microbiology. 6. 925–925. 9 indexed citations
11.
Lochmann, Timothy L., Ravindar R. Thomas, James P. Bennett, & Shirley M. Taylor. (2015). Epigenetic Modifications of the PGC-1α Promoter during Exercise Induced Expression in Mice. PLoS ONE. 10(6). e0129647–e0129647. 35 indexed citations
12.
Bann, Darrin V., et al.. (2013). Alterations in the MA and NC Domains Modulate Phosphoinositide-Dependent Plasma Membrane Localization of the Rous Sarcoma Virus Gag Protein. Journal of Virology. 87(6). 3609–3615. 25 indexed citations
13.
Lochmann, Timothy L., et al.. (2012). NC-mediated nucleolar localization of retroviral gag proteins. Virus Research. 171(2). 304–318. 32 indexed citations
14.
Kenney, Scott P., Timothy L. Lochmann, Cullen L. Schmid, & Leslie J. Parent. (2007). Intermolecular Interactions between Retroviral Gag Proteins in the Nucleus. Journal of Virology. 82(2). 683–691. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abdul Rouf Banday Breakdown of academic impact, for papers by Richard Kirkman Breakdown of academic impact, for papers by Nene N. Kalu Breakdown of academic impact, for papers by Laura Tsujikawa Breakdown of academic impact, for papers by Florence Le Roy Breakdown of academic impact, for papers by Stacy Moore Breakdown of academic impact, for papers by Chung-Chieh Chiao Breakdown of academic impact, for papers by Patrick Gonzalez Breakdown of academic impact, for papers by Jessica Koach Breakdown of academic impact, for papers by Edurne Gallastegui
Rankless by CCL
2026